-
1
-
-
0036792398
-
The history and future of the uorescence activated cell sorter and ow cytometry: a view from Stanford
-
Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA. The history and future of the uorescence activated cell sorter and ow cytometry: a view from Stanford. Clin Chem 2002;48:1819-27
-
(2002)
Clin Chem
, vol.48
, pp. 1819-1827
-
-
Herzenberg, L.A.1
Parks, D.2
Sahaf, B.3
Perez, O.4
Roederer, M.5
Herzenberg, L.A.6
-
2
-
-
1542514871
-
Twenty-ve years of clinical ow cytometry: AIDS accelerated global instrument distribution
-
Mandy FF. Twenty-ve years of clinical ow cytometry: AIDS accelerated global instrument distribution. Cytometry 2004;58A: 55-6
-
(2004)
Cytometry
, vol.58 A
, pp. 55-56
-
-
Mandy, F.F.1
-
5
-
-
0033884049
-
Flow cytometry: principles and clinical applications in hematology
-
Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem 2000;46:1221-9
-
(2000)
Clin Chem
, vol.46
, pp. 1221-1229
-
-
Brown, M.1
Wittwer, C.2
-
6
-
-
33845531087
-
Del Vecchio L Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'
-
Di Noto R, Mirabelli P, Del Vecchio L. Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'. Leukemia 2007;21:4-8
-
(2007)
Leukemia
, vol.21
, pp. 4-8
-
-
Di Noto, R.1
Mirabelli, P.2
-
7
-
-
24744447579
-
CD molecules2005 human cell differentiation molecules
-
Zola H, Swart B, Nicholson I, et al. CD molecules 2005: human cell differentiation molecules. Blood 2005;106:3123-6
-
(2005)
Blood
, vol.106
, pp. 3123-3126
-
-
Zola, H.1
Swart, B.2
Nicholson, I.3
-
8
-
-
41349113572
-
FMC7 is an epitope of CD20
-
Deans JP, Polyak MJ. FMC7 is an epitope of CD20. Blood 2008;111:2492
-
(2008)
Blood
, vol.111
, pp. 2492
-
-
Deans, J.P.1
Polyak, M.J.2
-
9
-
-
0026556554
-
Dead cell discrimination with 7-amino-actinomycin D in combination with dual colour immunouorescence in single laser ow cytometry
-
Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell discrimination with 7-amino-actinomycin D in combination with dual colour immunouorescence in single laser ow cytometry. Cytometry 1992;13:204-8
-
(1992)
Cytometry
, vol.13
, pp. 204-208
-
-
Schmid, I.1
Krall, W.J.2
Uittenbogaart, C.H.3
Braun, J.4
Giorgi, J.V.5
-
10
-
-
0032768827
-
Quality control of ow cytometric immunophenotyping of haematological malignancies
-
Gratama JW, Bolhuis RLH, Van't Veer MB. Quality control of ow cytometric immunophenotyping of haematological malignancies. Clin Lab Haem 1999;21:155-60
-
(1999)
Clin Lab Haem
, vol.21
, pp. 155-160
-
-
Gratama, J.W.1
Bolhuis, R.L.H.2
Van't Veer, M.3
-
11
-
-
0034699436
-
Validation and quality control of immunophenotyping in clinical ow cytometry
-
Owens MA, Vall HG, Hurley AA, Wormsley SB. Validation and quality control of immunophenotyping in clinical ow cytometry. J Immunol Methods 2000;243:33-50
-
(2000)
J Immunol Methods
, vol.243
, pp. 33-50
-
-
Owens, M.A.1
Vall, H.G.2
Hurley, A.A.3
Wormsley, S.B.4
-
12
-
-
0032522567
-
Single platform ow cytometric absolute CD34{thorn} cell counts based on the ISHAGE guidelines
-
Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform ow cytometric absolute CD34{thorn} cell counts based on the ISHAGE guidelines. Cytometry 1998;34:61-70
-
(1998)
Cytometry
, vol.34
, pp. 61-70
-
-
Keeney, M.1
Chin-Yee, I.2
Weir, K.3
Popma, J.4
Nayar, R.5
Sutherland, D.R.6
-
14
-
-
0035503984
-
Spectral compensation for ow cytometry: visualization artefacts, limitations, and caveats
-
Roederer M. Spectral compensation for ow cytometry: visualization artefacts, limitations, and caveats. Cytometry 2001;45:194-205
-
(2001)
Cytometry
, vol.45
, pp. 194-205
-
-
Roederer, M.1
-
17
-
-
0029760436
-
The ISHAGE guidelines for CD34+ cell determination by ow cytometry
-
Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by ow cytometry. J Hematother 1996;5:213-26
-
(1996)
J Hematother
, vol.5
, pp. 213-226
-
-
Sutherland, D.R.1
Anderson, L.2
Keeney, M.3
Nayar, R.4
Chin-Yee, I.5
-
19
-
-
32444433947
-
Quantitative ow cytometry in the clinical laboratory
-
Maher KJ, Fletcher MA. Quantitative ow cytometry in the clinical laboratory. Clin Appl Immunol Rev 2005;5:353-72
-
(2005)
Clin Appl Immunol Rev
, vol.5
, pp. 353-372
-
-
Maher, K.J.1
Fletcher, M.A.2
-
20
-
-
0036008654
-
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders
-
Bain BJ, Barnett D, Linch D, Matutes E, Reilly JT. Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haem 2002;24:1-13
-
(2002)
Clin Lab Haem
, vol.24
, pp. 1-13
-
-
Bain, B.J.1
Barnett, D.2
Linch, D.3
Matutes, E.4
Reilly, J.T.5
-
21
-
-
1842535086
-
Peripheral Blood CD34+ cell counts allow improved management of peripheral blood stem cell collections
-
Gibbs G, Bolam S. Peripheral Blood CD34+ cell counts allow improved management of peripheral blood stem cell collections. Br J Biomed Sci 2004;61:35-7
-
(2004)
Br J Biomed Sci
, vol.61
, pp. 35-37
-
-
Gibbs, G.1
Bolam, S.2
-
22
-
-
0036092789
-
Neutrophil CD64 expression: distinguishing acute inammatory autoimmune disease from systemic infections
-
Allen E, Bakke AC, Purtzer MZ, Deodhar A. Neutrophil CD64 expression: distinguishing acute inammatory autoimmune disease from systemic infections. Ann Rheum Dis 2002;61:522-5
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 522-525
-
-
Allen, E.1
Bakke, A.C.2
Purtzer, M.Z.3
Deodhar, A.4
-
23
-
-
0344667634
-
Multicenter clinical experience with ow cytometric method for fetomaternal hemorrhage detection
-
Chen JC, Davis BH, Wood B, Warzynski MJ. Multicenter clinical experience with ow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002;50:285-90
-
(2002)
Cytometry
, vol.50
, pp. 285-290
-
-
Chen, J.C.1
Davis, B.H.2
Wood, B.3
Warzynski, M.J.4
-
24
-
-
0037355339
-
Prognostic signicance of CD38 and CD20 expression as assessed by quantitative ow cytometry in chronic lymphocytic leukaemia
-
Hsi ED, Kopecky KJ, Appelbaum FR, et al. Prognostic signicance of CD38 and CD20 expression as assessed by quantitative ow cytometry in chronic lymphocytic leukaemia. Br J Haematol 2003;120:1017-25
-
(2003)
Br J Haematol
, vol.120
, pp. 1017-1025
-
-
Hsi, E.D.1
Kopecky, K.J.2
Appelbaum, F.R.3
-
25
-
-
33748512177
-
Quantitative ow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble uorochrome
-
Kay S, Herishanu Y, Pick M, et al. Quantitative ow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble uorochrome. Cytometry B 2006;70B:218-26
-
(2006)
Cytometry B
, vol.70 B
, pp. 218-226
-
-
Kay, S.1
Herishanu, Y.2
Pick, M.3
-
26
-
-
34447517121
-
Quality control in clinical ow cytometry
-
Oldaker TA. Quality control in clinical ow cytometry. Clin Lab Med 2007;27:671-85
-
(2007)
Clin Lab Med
, vol.27
, pp. 671-685
-
-
Oldaker, T.A.1
-
27
-
-
34447507803
-
More than just quality control
-
Carey JL, Oldaker TA. More than just quality control. Clin Lab Med 2007;27:687-707
-
(2007)
Clin Lab Med
, vol.27
, pp. 687-707
-
-
Carey, J.L.1
Oldaker, T.A.2
-
36
-
-
0003866728
-
Primary and Secondary Immunodeciencies
-
eds. Endocrine Disorders (Section 12).18th edn. New Jersey: Merck & Co
-
Beers MH, Porter RS, eds. Endocrine Disorders (Section 12). Primary and Secondary Immunodeciencies. In: The Merck Manual of Diagnosis and Therapy. 18th edn. New Jersey: Merck & Co, 2006
-
(2006)
The Merck Manual of Diagnosis and Therapy
-
-
Beers, M.H.1
Porter, R.S.2
-
37
-
-
0033397444
-
The use of ow cytometry to measure neutrophil function
-
van Eedena S, Kluta M, Walkerb B, et al. The use of ow cytometry to measure neutrophil function. J Imm Meth 1999;232:23-43
-
(1999)
J Imm Meth
, vol.232
, pp. 23-43
-
-
van Eedena, S.1
Kluta, M.2
Walkerb, B.3
-
39
-
-
22144497190
-
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
-
Chevalier P, Roland V, Mahe B, et al. Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia. Leuk Res 2005;29:103-7
-
(2005)
Leuk Res
, vol.29
, pp. 103-107
-
-
Chevalier, P.1
Roland, V.2
Mahe, B.3
-
40
-
-
31444453579
-
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism
-
Mone AP, Cheney C, Banks AL, et al. Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia 2006;20:272-9
-
(2006)
Leukemia
, vol.20
, pp. 272-279
-
-
Mone, A.P.1
Cheney, C.2
Banks, A.L.3
-
41
-
-
2642547946
-
Minimal residual disease studies by ow cytometry in acute leukemia
-
Campana D, Coustan-Smith E. Minimal residual disease studies by ow cytometry in acute leukemia. Acta Haematol 2004;112:8-15
-
(2004)
Acta Haematol
, vol.112
, pp. 8-15
-
-
Campana, D.1
Coustan-Smith, E.2
-
42
-
-
0037555007
-
Guidelines for the estimation of fetomaternal haemorrhage
-
Austin E, Bates S, de Silva M, et al. Guidelines for the estimation of fetomaternal haemorrhage. Transfus Med 1999;9:87-92
-
(1999)
Transfus Med
, vol.9
, pp. 87-92
-
-
Austin, E.1
Bates, S.2
de Silva, M.3
-
43
-
-
0001107677
-
Guideline for the ow cytometric enumeration of CD34+ haematopoietic stem cells
-
Barnett D, Janossy G, Lubenko A, et al. Guideline for the ow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haem 1999;21:301-8
-
(1999)
Clin Lab Haem
, vol.21
, pp. 301-308
-
-
Barnett, D.1
Janossy, G.2
Lubenko, A.3
-
45
-
-
84873067731
-
The management of paroxysmal nocturnal hemoglobinuria - recent advances in diagnosis and treatment, and new hope for patients
-
Schrezenmeier H, Höchsmann B. The management of paroxysmal nocturnal hemoglobinuria -recent advances in diagnosis and treatment, and new hope for patients. US Hematol 2009;2:74-80
-
(2009)
US Hematol
, vol.2
, pp. 74-80
-
-
Schrezenmeier, H.1
Höchsmann, B.2
-
46
-
-
0031959217
-
Rapid heterozygote detection in Glanzmann's thrombasthenia
-
Sharp WJ, Khanduri UD, Christie BS. Rapid heterozygote detection in Glanzmann's thrombasthenia. Br J Haematol 1998;101:66-9
-
(1998)
Br J Haematol
, vol.101
, pp. 66-69
-
-
Sharp, W.J.1
Khanduri, U.D.2
Christie, B.S.3
-
47
-
-
1542475297
-
Role of ow cytometry in the diagnostic evaluation of primary immunodeciency disease
-
O'Gorman M, Scholl P. Role of ow cytometry in the diagnostic evaluation of primary immunodeciency disease. Clin Appl Immunol Rev 2002;2:321-35
-
(2002)
Clin Appl Immunol Rev
, vol.2
, pp. 321-335
-
-
O'Gorman, M.1
Scholl, P.2
-
48
-
-
0032922549
-
A novel leukocyte adhesion deciency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1
-
Hogg N, Stewart MP, Scarth SL, et al. A novel leukocyte adhesion deciency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest 1999;103:97-106
-
(1999)
J Clin Invest
, vol.103
, pp. 97-106
-
-
Hogg, N.1
Stewart, M.P.2
Scarth, S.L.3
-
49
-
-
34447542504
-
Cellular image analysis and imaging by ow cytometry
-
Basiji D, Ortyn W, Liang L, et al. Cellular image analysis and imaging by ow cytometry. Clin Lab Med 2007;27:653-7
-
(2007)
Clin Lab Med
, vol.27
, pp. 653-657
-
-
Basiji, D.1
Ortyn, W.2
Liang, L.3
|